These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1592460)

  • 21. gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
    Wilk S; Mizoguchi H; Orlowski M
    J Pharmacol Exp Ther; 1978 Jul; 206(1):227-32. PubMed ID: 660553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sympathectomy does not modify the levels of dopa or dopamine in the rat dorsal root ganglion.
    Bertrand A; Weil-Fugazza J
    Brain Res; 1995 May; 681(1-2):201-4. PubMed ID: 7552281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal handling of dopa, dopamine, norepinephrine, and epinephrine in the dog.
    Ball SG; Gunn IG; Douglas IH
    Am J Physiol; 1982 Jan; 242(1):F56-62. PubMed ID: 6800262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
    Brown MJ; Dollery CT
    Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
    Armando I; Nowicki S; Aguirre J; Barontini M
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1087-92. PubMed ID: 7611449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertension: 3 H-catecholamine metabolism in the adrenal glands and brain and tissue metabolism of 3 3 H-DOPA during reserpine, alpha-methyl DOPA and ST-155 administration in spontaneously hypertensive rats].
    Hashida J
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):80-97. PubMed ID: 4734773
    [No Abstract]   [Full Text] [Related]  

  • 28. Losartan prevents the imbalance between renal dopaminergic and renin angiotensin systems induced by fructose overload. l-Dopa/dopamine index as new potential biomarker of renal dysfunction.
    Rukavina Mikusic NL; Kouyoumdzian NM; Uceda A; Del Mauro JS; Pandolfo M; Gironacci MM; Puyó AM; Toblli JE; Fernández BE; Choi MR
    Metabolism; 2018 Aug; 85():271-285. PubMed ID: 29727629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4-dihydroxyphenylalanine levels in rat brain.
    Westerink BH; van Es TP; Spaan SJ
    J Neurochem; 1982 Jul; 39(1):44-51. PubMed ID: 6123552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of thyroid hormone on the renal dopaminergic system.
    Del Compare JA; Aguirre JA; Ibarra FR; Barontini M; Armando I
    Endocrine; 2001 Aug; 15(3):297-303. PubMed ID: 11762703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats.
    Yue JL; Okumura Y; Miyamae T; Ueda H; Misu Y
    Neuroscience; 1995 Jul; 67(1):95-106. PubMed ID: 7477914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary dopamine and renal handling of L-DOPA in fasted spontaneously hypertensive rats.
    Dantonello TM; Küster E; Mühlbauer B
    Kidney Blood Press Res; 1998; 21(6):438-44. PubMed ID: 9933829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The heterogeneity of dopamine involvement in essential hypertension.
    Kuchel O
    Clin Exp Hypertens A; 1989; 11 Suppl 1():217-25. PubMed ID: 2663248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
    Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
    Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demethylation of 3-O-methyldopa in the kidney: a possible source for dopamine in urine.
    Ibarra FR; Aguirre J; Nowicki S; Barontini M; Arrizurieta EE; Armando I
    Am J Physiol; 1996 May; 270(5 Pt 2):F862-8. PubMed ID: 8928849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of renal dopaminergic activity on renal sodium-water metabolism in congestive heart failure.
    Hayashi M; Shimamoto K; Tsuchihashi K; Ishiguro T; Torii T; Sawai N; Mukai H; Iimura O
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):874-7. PubMed ID: 8911728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
    Jeffrey RF; MacDonald TM; Marwick K; Lee MR
    Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.
    Williams M; Young JB; Rosa RM; Gunn S; Epstein FH; Landsberg L
    J Clin Invest; 1986 Dec; 78(6):1687-93. PubMed ID: 3097077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced dopamine renal responsiveness in patients with hypertension.
    Andrejak M; Hary L
    Clin Pharmacol Ther; 1986 Dec; 40(6):610-4. PubMed ID: 3780122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension.
    Iimura O; Shimamoto K
    J Auton Pharmacol; 1990; 10 Suppl 1():s73-7. PubMed ID: 2098378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.